Why the study?
Does management of hypertension reduce cardiovascular risk and attenuate progression of CKD in patients with chronic kidney disease?
Population
Patients with hypertension and chronic kidney disease (CKD)
Design
Review
Authors
Loading...
May support hypertension management in CKD to reduce CV risk and slow progression; leaves optimal targets open for prospective trials.
Does management of hypertension reduce cardiovascular risk and attenuate progression of CKD in patients with chronic kidney disease?
This review examines the evidence for hypertension management as a strategy to reduce cardiovascular risk and slow CKD progression.
Botdorf et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: